年別の研究成果
年別の研究成果
研究成果
- 17 被引用数
- 2 h-index
- 5 Article
検索結果
-
2020
Truncated runx1 generated by the fusion of runx1 to antisense grik2 via a cryptic chromosome translocation enhances sensitivity to granulocyte colony-stimulating factor
Abe, A., Yamamoto, Y., Katsumi, A., Yamamoto, H., Okamoto, A., Inaguma, Y., Iriyama, C., Tokuda, M., Okamoto, M., Emi, N. & Tomita, A., 01-07-2020, In: Cytogenetic and Genome Research. 160, 5, p. 255-263 9 p.研究成果: Article › 査読
1 被引用数 (Scopus) -
2019
Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system
the New TARGET investigators, 05-04-2019, In: International Journal of Hematology. 109, 4, p. 426-439 14 p.研究成果: Article › 査読
10 被引用数 (Scopus) -
2018
Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD
Kato, H., Yamamoto, K., Kodaira, T., Higuchi, Y., Yamamoto, H., Saito, T., Taji, H., Yatabe, Y., Nakamura, S. & Kinoshita, T., 07-02-2018, In: Hematology. 23, 2, p. 83-88 6 p.研究成果: Article › 査読
Open Access -
2016
Anti-CCR4 Monoclonal Antibody Mogamulizumab Followed by the GDP (Gemcitabine, Dexamethasone and Cisplatin) Regimen in Primary Refractory Angioimmunoblastic T-Cell Lymphoma
Kato, H., Yamamoto, K., Higuchi, Y., Yamamoto, H., Saito, T., Taji, H., Yatabe, Y., Nakamura, S. & Kinoshita, T., 01-12-2016, In: Chemotherapy. 62, 1, p. 19-22 4 p.研究成果: Article › 査読
-
Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy
Murakami, S., Kato, H., Higuchi, Y., Yamamoto, K., Yamamoto, H., Saito, T., Taji, H., Yatabe, Y., Nakamura, S. & Kinoshita, T., 01-08-2016, In: Annals of Hematology. 95, 8, p. 1259-1269 11 p.研究成果: Article › 査読
6 被引用数 (Scopus)